Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

References

• EUROPLAN Partners Recommendations for the Development of National Plans for Rare Diseases Guidance Document 20100601 2010 Available from: http://www.europlanproject.eu/Resources/docs/2008-2011_2.EUROPLANRecommendations.pdf Accessed August 23, 2016
   Google Scholar
• Commission of the European Communities Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe’s Challenges 2008 Available from: http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf Accessed August 23, 2016
   Google Scholar
• EUR-Lex Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on Clinical Trials on Medicinal Products for Human Use, and Repealing Directive 2001/20/EC 2014 Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0536&qid=1421232837997&from=EN Accessed August 23, 2016
   Google Scholar
• United States Food and Drug Administration Department of Health and Human Services [webpage on the Internet] 21CFR316.20 – Content and Format of a Request for Orphan-Drug Designation 2015 Available from: http://www.ecfr.gov/cgi-bin/text-idx?SID=ad1729044e3018c44badef3eb3824efe&mc=true&node=se21.5.316_120&rgn=div8 Accessed August 23, 2016
   Google Scholar
• European Medicines Agency Points to Consider on the Calculation and Reporting of the Prevalence of a Condition for Orphan Designation 2002 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/09/WC500003773.pdf Accessed August 24, 2016
   Google Scholar
• Harknett EC Chang WY Byrnes S Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis QJM 2011 104 11 971 979 21764810
   PubMed Web of Science ®Google Scholar
• Leadley RM Lang S Misso K A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases Orphanet J Rare Dis 2014 9 173 25404155
   PubMed Web of Science ®Google Scholar
• Hallal C Kieling CO Nunes DL Diagnosis, misdiagnosis, and associated diseases of achalasia in children and adolescents: a twelve-year single center experience Pediatr Surg Int 2012 28 12 1211 1217 23135808
   PubMed Web of Science ®Google Scholar
• Rother KI Brown RJ Novel forms of lipodystrophy: why should we care? Diabetes Care 2013 36 8 2142 2145 23881965
   PubMed Web of Science ®Google Scholar
• Alpsoy E Akman-Karakas A Uzun S Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid Arch Dermatol Res 2015 307 4 291 298 25589418
   PubMed Web of Science ®Google Scholar
• Cuchel M Bruckert E Ginsberg HN Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society Eur Heart J 2014 35 32 2146 2157 25053660
   PubMed Web of Science ®Google Scholar
• Brown RJ Araujo-Vilar D Cheung PT The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline J Clin Endocrinol Metab 2016 101 12 4500 4511 27710244
   PubMed Web of Science ®Google Scholar
• Garg A Clinical review: lipodystrophies: genetic and acquired body fat disorders J Clin Endocrinol Metab 2011 96 11 3313 3325 21865368
   PubMed Web of Science ®Google Scholar
• Misra A Peethambaram A Garg A Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature Medicine 2004 83 1 18 34 14747765
   PubMed Web of Science ®Google Scholar
• Garg A Lipodystrophies Am J Med 2000 108 2 143 152 11126308
   PubMed Web of Science ®Google Scholar
• Misra A Garg A Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature Medicine (Baltimore) 2003 82 2 129 146 12640189
   PubMed Web of Science ®Google Scholar
• Garg A Peshock RM Fleckenstein JL Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety) J Clin Endocrinol Metab 1999 84 1 170 174 9920078
   PubMed Web of Science ®Google Scholar
• Handelsman Y Oral EA Bloomgarden ZT The clinical approach to the detection of lipodystrophy – an AACE consensus statement Endocr Pract 2013 19 1 107 116 23435042
   PubMed Web of Science ®Google Scholar
• Lotta LA Gulati P Day FR Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance Nat Genet 2017 49 1 17 26 27841877
   PubMed Web of Science ®Google Scholar
• Savage DB Semple RK Clatworthy MR Complement abnormalities in acquired lipodystrophy revisited J Clin Endocrinol Metab 2009 94 1 10 16 18854390
   PubMed Web of Science ®Google Scholar
• European Medicines Agency Public Summary of Opinion on Orphan Designation: Metreleptin for the Treatment of Berardinelli-Seip Syndrome 2015 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2012/08/WC500131635.pdf Accessed August 30, 2016
   Google Scholar
• European Medicines Agency Public Summary of Opinion on Orphan Designation: Metreleptin for the Treatment of Lawrence Syndrome 2015 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2012/08/WC500131630.pdf Accessed August 30, 2016
   Google Scholar
• European Medicines Agency Public Summary of Opinion on Orphan Designation: Metreleptin for the Treatment of Barraquer-Simons Syndrome 2015 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2012/08/WC500131630.pdf Accessed August 30, 2016
   Google Scholar
• European Medicines Agency Public Summary of Opinion on Orphan Designation: Metreleptin for the Treatment of Familial Partial Lipodystrophy 2015 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2012/08/WC500131629.pdf Accessed August 30, 2016
   Google Scholar
• Garg A Acquired and inherited lipodystrophies N Engl J Med 2004 350 12 1220 1234 15028826
   PubMed Web of Science ®Google Scholar
• van Maldergem L database on the Internet Berardinelli-Seip Congenital Lipodystrophy 2009 Available from: http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=1007&Disease_Disease_Search_diseaseGroup=congenital-generalized-lipodystrophy&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Berardinelli-Seip-congenital-lipodystrophy&title=Berardinelli-Seip-congenital-lipodystrophy&search=Disease_Search_Simple Accessed August 30, 2016
   Google Scholar
• Vantyghem M-C database on the Internet Partial Acquired Lipodystrophy 2006 Available from: http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=11131&Disease_Disease_Search_diseaseGroup=79087&Disease_Disease_Search_diseaseType=ORPHA&Disease(s)/group%20of%20diseases=Partial-acquired-lipodystrophy&title=Partial-acquired-lipodystrophy&search=Disease_Search_Simple Accessed August 30, 2016
   Google Scholar
• Vantyghem M-C database on the Internet Acquired Generalized Lipodystrophy 2009 Available from: http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=11130&Disease_Disease_Search_diseaseGroup=acquired-generalized-lipodystrophy&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Acquired-generalized-lipodystrophy&title=Acquired-generalized-lipodystrophy&search=Disease_Search_Simple Accessed August 30, 2016
   Google Scholar
• Vigouroux C database on the Internet Familial Partial Lipodystrophy 2015 Available from: http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=13323&Disease_Disease_Search_diseaseGroup=familial-partial-lipodystrophy&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Familial-partial-lipodystrophy&title=Familial-partial-lipodystrophy&search=Disease_Search_Simple Accessed August 30, 2016
   Google Scholar
• United States Food and Drug Administration Department of Health and Human Services [webpage on the Internet] FAQ Document 2015 2015 Available from: https://www.fda.gov/ForIndustry/DevelopingProducts-forRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/ucm240819.htm Accessed March 1, 2017
   Google Scholar
• Brown LD Cat TT DasGupta A Interval estimation for a proportion Stat Sci 2001 16 101 133
   Web of Science ®Google Scholar
• Sergeant ESG [webpage on the Internet] Epitools Epidemiological Calculators 2017 Available from: http://epitools.ausvet.com.au/content.php?page=CIProportion Accessed May 4, 2017
   Google Scholar
• Akinci B Onay H Demir T Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey J Clin Endocrinol Metab 2016 101 7 2759 2767 27144933
   PubMed Web of Science ®Google Scholar